Tag Archives: strategy

(Veloci)Raptor’s Rapture

Posted on May 2, 2013 by BioChef in Training

Look. It’s done. Indeed. Believe it or not, this is the second post of the year…and within 10 days of the first. Twice 2012’s output already.  More shocking than ODAC’s resounding rejection of $AVEO’s tivozanib on today! —————————————————————————————————————————- I wanted … Continue reading →

Posted in I don't get it, Orphan, Pricing, Update | Tagged , , , , , , , , | Leave a comment

Bittersweet hESCs, $GERN

Posted on November 15, 2011 by BioChef in Training

Bittersweet to see Geron ($GERN) drop their embryonic stem cell (ESC) program. On one hand, the science is pretty cool and much has been learned with $GERN leading the way. But, on the other, the bar for safety and efficacy … Continue reading →

Posted in Uncategorized | Tagged , , , , , | 1 Comment

$MYRX, running down a dream

Posted on September 14, 2011 by BioChef in Training

What should you do when biotech companies trade below cash and have early stage assets in development? While each case is unique (e.g. did it crash after a failed trial or did investors not approve of a reverse merge into … Continue reading →

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Sell in May, and go away?

Posted on May 12, 2011 by BioChef in Training

While some investors might heed the “Sell in May, and go away” mantra, if you’re a little guy looking for ideas in biotech, going away in June is probably more realistic. Better for me, as it coincides with the end … Continue reading →

Posted in Why did they do that? | Tagged , , , , | 1 Comment